Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
EURTAC is the First Phase III Study to Show Progression-Free Survival Benefit of First-Line Tarceva in a Western Population with Advanced Lung Cancer With EGFR Mutations SOUTH SAN FRANCISCO,...
Tokyo, – January 10, 2011 – Astellas Pharma Inc. (TSE: 4503) announced today that it has engaged Citigroup Global Markets Inc. to conduct, in conjunction with executive management, a review of...
Read more about Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary
48 Middle and Secondary School Science Teachers From Across the Country to Begin Year-long Professional Development Journey ARLINGTON, Va. — November 15, 2010 — The National Science Teachers...
Read more about 2010 NSTA New Science Teacher Academy Fellows Announced
TOKYO, Nov. 2, 2010 /PRNewswire/ -- Astellas Pharma Inc. ("Astellas"; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that Donald B. Rice, PhD. will retire from Astellas...
CHICAGO and DEERFIELD, Ill., Nov. 2, 2010 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a research-based pharmaceutical company based in Deerfield, Ill., is pleased to donate 150 used...
Read more about Astellas Donates 150 Laptop Computers to Help Inner-City Chicago Students
K-12 Science Teachers and Parents Also Agree Outside Mentors and Use of Technology Resources Can Play an Important Role CHICAGO AND DEERFIELD, IL, October 28, 2010 – A new national survey...
Phase IV Data Meets Primary Endpoint PHILADELPHIA, PA, September 25, 2010 – Today Astellas Pharma US, Inc., (“Astellas”) announced results of a Phase IV study showing Lexiscan®...
PHILADELPHIA, PA, September 24, 2010 - Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for...
Read more about New Smartphone App Launches For Cardiac Imaging Test
DEERFIELD, IL, September 15, 2010 – Astellas Pharma US, Inc. has announced the winners of the second 2010 Transplant Scholars Awards, which awarded a dozen $5,000 educational scholarships to...
SANTA MONICA, Calif.- Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate...
Follow U.S. news
